| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |